Literature DB >> 21762456

Common membrane trafficking defects of disease-associated dynamin 2 mutations.

Ya-Wen Liu1, Vasyl Lukiyanchuk, Sandra L Schmid.   

Abstract

Dynamin (Dyn) is a multidomain and multifunctional GTPase best known for its essential role in clathrin-mediated endocytosis (CME). Dyn2 mutations have been linked to two human diseases, centronuclear myopathy (CNM) and Charcot-Marie-Tooth (CMT) disease. Paradoxically, although Dyn2 is ubiquitously expressed and essential for embryonic development, the disease-associated Dyn2 mutants are autosomal dominant, but result in slowly progressing and tissue-specific diseases. Thus, although the cellular defects that cause disease remain unclear, they are expected to be mild. To gain new insight into potential pathogenic mechanisms, we utilized mouse Dyn2 conditional knockout cells combined with retroviral-mediated reconstitution to mimic both heterozygous and homozygous states and characterized cellular phenotypes using quantitative assays for several membrane trafficking events. Surprisingly, none of the four mutants studied exhibited a defect in CME, but all were impaired in their ability to support p75/neurotrophin receptor export from the Golgi, the raft-dependent endocytosis of cholera toxin and the clathrin-independent endocytosis of epidermal growth factor receptor (EGFR). While it will be important to study these mutants in disease-relevant muscle and neuronal cells, given the importance of neurotrophic factors and lipid rafts in muscle physiology, we speculate that these common cellular defects might contribute to the tissue-specific diseases caused by a ubiquitously expressed protein.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762456      PMCID: PMC3188678          DOI: 10.1111/j.1600-0854.2011.01250.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  78 in total

1.  Ubiquitously expressed dynamin-II has a higher intrinsic GTPase activity and a greater propensity for self-assembly than neuronal dynamin-I.

Authors:  D E Warnock; T Baba; S L Schmid
Journal:  Mol Biol Cell       Date:  1997-12       Impact factor: 4.138

2.  Role of dynamin in the formation of transport vesicles from the trans-Golgi network.

Authors:  S M Jones; K E Howell; J R Henley; H Cao; M A McNiven
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

Review 3.  The dynamins: redundant or distinct functions for an expanding family of related GTPases?

Authors:  R Urrutia; J R Henley; T Cook; M A McNiven
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Role of the basic, proline-rich region of dynamin in Src homology 3 domain binding and endocytosis.

Authors:  P M Okamoto; J S Herskovits; R B Vallee
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

5.  Crystal structure of the pleckstrin homology domain from dynamin.

Authors:  D Timm; K Salim; I Gout; L Guruprasad; M Waterfield; T Blundell
Journal:  Nat Struct Biol       Date:  1994-11

6.  Crystal structure at 2.2 A resolution of the pleckstrin homology domain from human dynamin.

Authors:  K M Ferguson; M A Lemmon; J Schlessinger; P B Sigler
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

7.  Control of EGF receptor signaling by clathrin-mediated endocytosis.

Authors:  A V Vieira; C Lamaze; S L Schmid
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

8.  A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast.

Authors:  J Laporte; L J Hu; C Kretz; J L Mandel; P Kioschis; J F Coy; S M Klauck; A Poustka; N Dahl
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

9.  Identification of the binding site for acidic phospholipids on the pH domain of dynamin: implications for stimulation of GTPase activity.

Authors:  J Zheng; S M Cahill; M A Lemmon; D Fushman; J Schlessinger; D Cowburn
Journal:  J Mol Biol       Date:  1996-01-12       Impact factor: 5.469

10.  Dynamin-mediated internalization of caveolae.

Authors:  J R Henley; E W Krueger; B J Oswald; M A McNiven
Journal:  J Cell Biol       Date:  1998-04-06       Impact factor: 10.539

View more
  28 in total

1.  A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.

Authors:  Nicholas G James; Michelle A Digman; Justin A Ross; Barbara Barylko; Lei Wang; Jinhui Li; Yan Chen; Joachim D Mueller; Enrico Gratton; Joseph P Albanesi; David M Jameson
Journal:  Biochim Biophys Acta       Date:  2013-09-07

2.  Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.

Authors:  Johann Böhm; Valérie Biancalana; Elizabeth T Dechene; Marc Bitoun; Christopher R Pierson; Elise Schaefer; Hatice Karasoy; Melissa A Dempsey; Fabrice Klein; Nicolas Dondaine; Christine Kretz; Nicolas Haumesser; Claire Poirson; Anne Toussaint; Rebecca S Greenleaf; Melissa A Barger; Lane J Mahoney; Peter B Kang; Edmar Zanoteli; John Vissing; Nanna Witting; Andoni Echaniz-Laguna; Carina Wallgren-Pettersson; James Dowling; Luciano Merlini; Anders Oldfors; Lilian Bomme Ousager; Judith Melki; Amanda Krause; Christina Jern; Acary S B Oliveira; Florence Petit; Aurélia Jacquette; Annabelle Chaussenot; David Mowat; Bruno Leheup; Michele Cristofano; Juan José Poza Aldea; Fabrice Michel; Alain Furby; Jose E Barcena Llona; Rudy Van Coster; Enrico Bertini; Jon Andoni Urtizberea; Valérie Drouin-Garraud; Christophe Béroud; Bernard Prudhon; Melanie Bedford; Katherine Mathews; Lori A H Erby; Stephen A Smith; Jennifer Roggenbuck; Carol A Crowe; Allison Brennan Spitale; Sheila C Johal; Anthony A Amato; Laurie A Demmer; Jessica Jonas; Basil T Darras; Thomas D Bird; Mercy Laurino; Selman I Welt; Cynthia Trotter; Pascale Guicheney; Soma Das; Jean-Louis Mandel; Alan H Beggs; Jocelyn Laporte
Journal:  Hum Mutat       Date:  2012-04-04       Impact factor: 4.878

Review 3.  Muscle MRI in pediatrics: clinical, pathological and genetic correlation.

Authors:  Claudia P Cejas; Maria M Serra; David F Gonzalez Galvez; Eliana A Cavassa; Ana L Taratuto; Gabriel A Vazquez; Mario E L Massaro; Angeles V Schteinschneider
Journal:  Pediatr Radiol       Date:  2017-01-19

4.  Dynamin 2 homozygous mutation in humans with a lethal congenital syndrome.

Authors:  Olga S Koutsopoulos; Christine Kretz; Claudia M Weller; Aurelien Roux; Halina Mojzisova; Johann Böhm; Catherine Koch; Anne Toussaint; Emilie Heckel; Daphne Stemkens; Simone A J Ter Horst; Christelle Thibault; Muriel Koch; Syed Q Mehdi; Emilia K Bijlsma; Jean-Louis Mandel; Julien Vermot; Jocelyn Laporte
Journal:  Eur J Hum Genet       Date:  2012-10-24       Impact factor: 4.246

5.  Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.

Authors:  Elizabeth M Gibbs; Nigel F Clarke; Kristy Rose; Emily C Oates; Richard Webster; Eva L Feldman; James J Dowling
Journal:  J Mol Med (Berl)       Date:  2013-01-22       Impact factor: 4.599

6.  Brain slice biotinylation: an ex vivo approach to measure region-specific plasma membrane protein trafficking in adult neurons.

Authors:  Luke R Gabriel; Sijia Wu; Haley E Melikian
Journal:  J Vis Exp       Date:  2014-04-03       Impact factor: 1.355

Review 7.  Role of dynamin 2 in the disassembly of focal adhesions.

Authors:  Laura Briñas; Stéphane Vassilopoulos; Gisèle Bonne; Pascale Guicheney; Marc Bitoun
Journal:  J Mol Med (Berl)       Date:  2013-04-23       Impact factor: 4.599

8.  Development of AD-Like Pathology in Skeletal Muscle.

Authors:  X Chen; N M Miller; Z Afghah; J D Geiger
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2019-04-02

9.  Dynamics of intracellular clathrin/AP1- and clathrin/AP3-containing carriers.

Authors:  Comert Kural; Silvia K Tacheva-Grigorova; Steeve Boulant; Emanuele Cocucci; Thorsten Baust; Delfim Duarte; Tom Kirchhausen
Journal:  Cell Rep       Date:  2012-10-25       Impact factor: 9.423

10.  Dynamin 2 regulates biphasic insulin secretion and plasma glucose homeostasis.

Authors:  Fan Fan; Chen Ji; Yumei Wu; Shawn M Ferguson; Natalia Tamarina; Louis H Philipson; Xuelin Lou
Journal:  J Clin Invest       Date:  2015-09-28       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.